Wikipedia:Version 1.0 Editorial Team/Pharmacology articles by quality log
Jump to navigation
Jump to search
![]() | This is a log of operations by a bot. The contents of this page are unlikely to need human editing. In particular, links should not be disambiguated as this is a historical record. |
July 17, 2024
[edit]Reassessed
[edit]- BU72 (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
- Bimekizumab (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
- Dapagliflozin/saxagliptin (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
- Doxacurium chloride (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
- Rhynchophylline (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
- Tautomycin (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
- Velaglucerase alfa (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
- Vildagliptin/metformin (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
July 16, 2024
[edit]Renamed
[edit]- Draft:Klick (company) renamed to Klick (company).
Reassessed
[edit]- Alimemazine (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
- Arginine/lysine (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
- Imidacloprid/moxidectin (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
- Imlifidase (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
- Lipegfilgrastim (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
- Motixafortide (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
- Netarsudil/latanoprost (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
- Nicotine pouch (talk) reassessed. Quality rating changed from B-Class to Redirect-Class. (rev · t)
- Pelubiprofen (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
- Pozelimab (talk) reassessed. Quality rating changed from Stub-Class to B-Class. (rev · t)
July 15, 2024
[edit]Assessed
[edit]- Sagopilone (talk) assessed. Quality assessed as C-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
July 14, 2024
[edit]Assessed
[edit]- Aspoxicillin (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Disitamab vedotin (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
July 13, 2024
[edit]Reassessed
[edit]- Latanoprostene bunod (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
- Pixantrone (talk) reassessed. Importance rating changed from Low-Class to Mid-Class. (rev · t)
Assessed
[edit]- Drug antagonism (talk) assessed. Quality assessed as B-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
July 12, 2024
[edit]Renamed
[edit]- Trevena Inc renamed to Trevena, Inc..
Reassessed
[edit]- CI-966 (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
- CI-988 (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
- Exisulind (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Assessed
[edit]- Trevena, Inc. (talk) assessed. Quality assessed as NA-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
July 11, 2024
[edit]Reassessed
[edit]- 3D printed medication (talk) reassessed. Quality rating changed from NA-Class to C-Class. (rev · t)